
    
      To evaluate the effect of fluconazole and/or ibuprofen on the urinary excretion of two
      vasoactive arachidonic acid products, thromboxane A2 (TXA2) and prostacycline (PGI2), in
      newborn infants treated with one or both of these drugs because of fungal infection
      prophylaxis and/or patent ductus arteriosis (PDA), respectively, as measurement of the
      possible interactions between these drugs.
    
  